Other product revenues — Product revenues, net
Vertex Pharmaceuticals Other product revenues — Product revenues, net increased by 35.0% to $237.40M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 24.2%, from $191.20M to $237.40M. Over 2 years (FY 2022 to FY 2025), Other product revenues — Product revenues, net shows a downward trend with a -18.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase suggests successful commercialization or market penetration of secondary assets, while a decrease may indicate declining demand for legacy products or a strategic shift in focus.
Detailed definition
This metric represents the net revenue generated from secondary or non-core pharmaceutical product lines outside of the...
Peer comparison
Peers often report this as 'Other Revenue' or 'Non-Core Product Sales,' and it is typically compared against the revenue growth rates of primary therapeutic franchises to determine portfolio balance.
vrtx_segment_other_product_revenues_product_revenues_netHistorical Data
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $310.98M | $310.98M | $310.98M | $310.98M | $209.20M | $207.00M | $196.40M | $186.90M | $191.20M | $170.80M | $236.10M | $175.80M | $237.40M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -32.7% | -1.1% | -5.1% | -4.8% | +2.3% | -10.7% | +38.2% | -25.5% | +35.0% |
| YoY Change | — | — | — | — | -32.7% | — | — | -10.7% | — | -17.5% | +20.2% | -5.9% | +24.2% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's other product revenues — product revenues, net?
- Vertex Pharmaceuticals (VRTX) reported other product revenues — product revenues, net of $237.40M in Q4 2025.
- How has Vertex Pharmaceuticals's other product revenues — product revenues, net changed year-over-year?
- Vertex Pharmaceuticals's other product revenues — product revenues, net increased by 24.2% year-over-year, from $191.20M to $237.40M.
- What is the long-term trend for Vertex Pharmaceuticals's other product revenues — product revenues, net?
- Over 2 years (2022 to 2025), Vertex Pharmaceuticals's other product revenues — product revenues, net has grown at a -18.8% compound annual growth rate (CAGR), from $1.24B to $820.10M.
- What does other product revenues — product revenues, net mean?
- Net revenue generated from the company's secondary or non-core pharmaceutical product offerings.